Technology/Digital Health
Emily Bernstein, Ph.D. (she/her/hers)
Clinical Psychologist
Massachusetts General Hospital/Harvard Medical School
SOMERVILLE, Massachusetts, United States
Caitlin Stamatis, Ph.D. (she/her/hers)
Akili Interactive Labs
Boston, Massachusetts, United States
Emily Bernstein, Ph.D. (she/her/hers)
Clinical Psychologist
Massachusetts General Hospital/Harvard Medical School
SOMERVILLE, Massachusetts, United States
Valerie Forman-Hoffman, M.P.H., Ph.D. (she/her/hers)
Woebot Health
North Liberty, Iowa, United States
Leah Tanner, M.P.H. (she/her/hers)
Headspace
Santa Monica, California, United States
Page Anderson, ABPP (she/her/hers)
Georgia State University
Decatur, Georgia, United States
Delivery of cognitive behavioral therapies via smartphone has excellent potential to address America’s mental health treatment gap. Over 85% of the U.S. population owns a smartphone, and ownership rates are similar across racial, ethnic, and sexual minority populations and among adults in outpatient community-based clinics. Thus, the majority of people in need of mental healthcare in the U.S. could access smartphone therapy if the appropriate intervention were available. A growing body of research also shows that smartphone therapy is efficacious for many emotional concerns. As many validated smartphone therapies can be implemented with minimal clinician time, these solutions are highly scalable and could rapidly reach historically excluded communities.
Despite the proliferation and promise of smartphone therapies, these treatments have not yet significantly improved care. One issue is that it remains unclear how people should be using these tools. We know that uptake and retention with digital treatments are problematically low and that some amount of use is necessary for said treatments to yield positive clinical effects. Beyond that, however, the field lacks data-driven guidance for optimal engagement. How often should patients log into an app or communicate with their coach? Do longer, less frequent sessions lead to better outcomes than short, frequent log-ins? Does it matter what content patients come back to or when? Should we nudge patients towards a specific way of using a treatment or support a more self-directed journey? What design or implementation strategies will keep patients coming back? How do we know if a patient is using digital treatment “correctly”?
It is necessary to think beyond early, one-size-fits-all, overly simplified metrics like number of log-ins or minutes spent on an app. It is time to work with patients and real world data to redefine engagement and move us closer to personalized, precision solutions. This symposium brings together multidisciplinary perspectives from researchers, clinicians, and industry leaders to address these critical questions. We will present new research on novel approaches for operationalizing meaningful engagement and using insights to inform treatment design and implementation. Speakers will investigate how to tailor their methods and recommendations for diverse products or populations and center users’ preferences and perspectives to prioritize equity, sustainability, and impact. Audience members will be introduced to multiple types of digital tools (e.g., guided and unguided apps, chatbots) and hear about studies with various populations (e.g., Gen Z, users with diverse gender identities, adults with body image concerns).
Speaker: Emily E. Bernstein, Ph.D. (she/her/hers) – Massachusetts General Hospital/Harvard Medical School
Co-author: Jennifer L. L. Greenberg, Psy.D. – Massachusetts General Hospital/Harvard Medical School
Co-author: Hilary Weingarden, Ph.D. (she/her/hers) – Massachusetts General Hospital
Co-author: Ivar Snorrason, PhD (he/him/his) – Massachusetts General Hospital / Harvard Medical School
Co-author: Berta Summers, PhD (she/her/hers) – Massachusetts General Hospital
Co-author: Jasmine Williams, B.A. – Massachusetts General Hospital
Co-author: Rachel E. Quist, B.A. – Massachusetts General Hospital
Co-author: Joshua Curtiss, M.A., Ph.D. – Northeastern University
Co-author: Oliver Harrison, MA, MBBS, MPH – Koa Health
Co-author: Sabine Wilhelm, Ph.D. (she/her/hers) – Harvard Medical School
Speaker: Valerie Forman-Hoffman, M.P.H., Ph.D. (she/her/hers) – Woebot Health
Co-author: Megan Flom, Ph.D. – Woebot Health
Co-author: Stephanie Eaneff, MSP (she/her/hers) – Woebot Health
Co-author: Timothy Campellone, PhD (he/him/his) – Woebot Health
Co-author: timothy Mariano, MD, PhD, MSc, MSIEEE (he/him/his) – Woebot Health
Speaker: Leah Tanner, M.P.H. (she/her/hers) – Headspace
Speaker: Page L. Anderson, ABPP (she/her/hers) – Georgia State University
Co-author: Heather D. Quirk, None – Georgia State University